Responsibilities of the team, page-96

First 96 Last

Share
Profile

Follow
Titans19

2,900 Posts.

1293

14/02/20

21:06

Post #: 42945328
Share

Originally posted by Aqua65: ↑

I don’t think there would be this sort of dilution - 50 million shares. No . Way too high .

Even if there were, fully diluted - my guesstimate , is it could only be by issuing of options , still, eg. to key stakeholders .
Who will hold them, or Hold the shares .
The management team , these men are the people doing the seriously , intense and high experience required work here with Bisantrene of course . They are not going to risk all their work or have it taken too cheaply.

Key management notably : Hold onto their - Options / or the Shares .
To protect their investment, not for selfish reasons as in to hold and not sell into the market , accumulation - but seriously because they are key stakeholders and this management , they are Serious. Final market capitalisation is what matters and theirs and everyones share of this .
* They protect all shareholders and the shareprice - which is market cap. also .
Issuing more shares - dilutes this .

And - more importantly :
These men , knew and calculated from the outset that they could Hold their positions , through all the journey and whatever work will be done .

This was very important- to them , to maximise and insure their own work and return on sweat to be worth it beyond the worthwhile task of bringing back Bisantrene or other worthy drugs , but for their own reputation and the personal huge work and investment, that this is worthwhile and has integrity , important to do .
With all the compromises and sacrifices required from their own lives - they are backing themselves and have everyone’s backs including their own !

By rigidly holding out as much as possible against dilution they also earn more value for their work and the company in the end . For sure .
And NO Lowball manipulation or loss of control as time goes by .
I am very grateful to them .

The management teams Holding alone is above the key 35-40 % level - prevents suppression and pressure on the shareprice.

In short -
Mainly I have huge , serious, respect for and am in awe of , this management team; and am very keen for this drug prospect to be brought into the clinics and market and available for a broad number of very dire and acute cancers , hopefully including breast & ovarian cancers.

I am thankful for the calibre and very high qualifications and expertise of this management team .
And for their capacity to do this - bring back Bisantrene.

Expand

Hi Aqua,

I 100% agree. This is a great team at RAC. Especially including the overlooked Dr C, Dr G and PM.

I also don't want dilution as I did the numbers last week and it would result in a difference of approximately $600,000 to me based on a CR with an extra 35m shares if they get taken over in 3 years for $1.5b... this is pittance compared to management, but is a lot to me.

I was simply asking what would be worse - partnership or CR? I'm not sure. Was also wondering if JDP found any examples with companies like RAC as I didn't.

RAC need anything from $8-15m at some point in time - which we know isn't an issue and currently the options will cover just about all of that - but if not 50m @ 30c would also do it (not my preference, but simply an example for comparison).

Cheers!

RAC Price at posting: 34.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply